- Home
- ESLA vs HXHX Comparison
ESLA vs HXHX Comparison
Compare ESLA & HXHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- HXHX
- Stock Information
- Founded
- ESLA 2021
- HXHX 2003
- Country
- ESLA United States
- HXHX China
- Employees
- ESLA N/A
- HXHX N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- HXHX Trucking Freight/Courier Services
- Sector
- ESLA Health Care
- HXHX Industrials
- Exchange
- ESLA Nasdaq
- HXHX Nasdaq
- Market Cap
- ESLA 32.1M
- HXHX 36.9M
- IPO Year
- ESLA N/A
- HXHX 2025
- Fundamental
- Price
- ESLA $1.02
- HXHX $1.69
- Analyst Decision
- ESLA Strong Buy
- HXHX
- Analyst Count
- ESLA 1
- HXHX 0
- Target Price
- ESLA $16.00
- HXHX N/A
- AVG Volume (30 Days)
- ESLA 79.4K
- HXHX 2.3M
- Earning Date
- ESLA 05-14-2025
- HXHX 01-01-0001
- Dividend Yield
- ESLA N/A
- HXHX N/A
- EPS Growth
- ESLA N/A
- HXHX N/A
- EPS
- ESLA N/A
- HXHX 0.30
- Revenue
- ESLA N/A
- HXHX $25,712,499.00
- Revenue This Year
- ESLA N/A
- HXHX N/A
- Revenue Next Year
- ESLA N/A
- HXHX N/A
- P/E Ratio
- ESLA N/A
- HXHX $5.91
- Revenue Growth
- ESLA N/A
- HXHX N/A
- 52 Week Low
- ESLA $0.63
- HXHX $1.58
- 52 Week High
- ESLA $3.23
- HXHX $6.29
- Technical
- Relative Strength Index (RSI)
- ESLA 58.11
- HXHX N/A
- Support Level
- ESLA $0.78
- HXHX N/A
- Resistance Level
- ESLA $0.87
- HXHX N/A
- Average True Range (ATR)
- ESLA 0.11
- HXHX 0.00
- MACD
- ESLA 0.02
- HXHX 0.00
- Stochastic Oscillator
- ESLA 92.80
- HXHX 0.00
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.